ResMed (RMD) total debt

Total debt · fiscal 2026
$825.92M

ResMed (RMD) carried total debt of $825.92M at the end of fiscal 2026 (June 30, 2026). That is 3.0% lower than the $851.81M of fiscal 2025. Figures as of 18 Nov 2026, 04:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2026
$825.92M
Change on fiscal 2025
−3.0%
Growth, 5 years
+4.7% a year
Growth, 10 years
−5.6% a year
Highest on record
$1.58Bfiscal 2023
Lowest on record
$100.16Mfiscal 2011
Fiscal years on record
172010–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed total debt, in more detail

Over the five fiscal years to 2026 total debt grew at a compound 4.7% a year; over ten years the rate was −5.6% a year. Across the 17 fiscal years on record (2010–2026), the highest was $1.58B in fiscal 2023 and the lowest $100.16M in fiscal 2011.

Total debt was 0.1× shareholders' equity at the end of fiscal 2026.

History · 17 fiscal years

Total debt by fiscal year

ResMed total debt, year by year

ResMed (RMD) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2026$825.92M 3.0% down0.1×
2025$851.81M 2.5% down0.1×
2024$873.94M 44.7% down0.2×
2023$1.58B 103.8% up0.4×
2022$775.24M 18.3% up0.2×
2021$655.35M 44.3% down0.2×
2020$1.18B 7.5% down0.5×
2019$1.27B 351.5% up0.6×
2018$281.45M 73.9% down0.1×
2017$1.08B 26.7% down0.6×
2016$1.47B 389.8% up0.9×
2015$300.59M 0.1% down0.2×
2014$300.79M 0.0% up0.2×
2013$300.79M 19.9% up0.2×
2012$250.84M 150.4% up0.2×
2011$100.16M 17.7% down0.1×
2010$121.69M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of ResMed and comparable companies
CompanyTotal debtFiscal year
Mettler-Toledo International MTD$2.15B2025
Centene CNC$18.16B2025
Genmab GMAB$5.43B2025
Illumina ILMN$2.55B2025
ResMed RMD$825.92M2026
Zoetis ZTS$9.24B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed total debt: questions and answers

How much debt does ResMed have?

ResMed (RMD) carried total debt of $825.92M at the end of fiscal 2026 (June 30, 2026). That is 3.0% lower than the $851.81M of fiscal 2025.

What is the growth rate of ResMed's total debt?

Over the five fiscal years to 2026 total debt grew at a compound 4.7% a year; over ten years the rate was −5.6% a year.

What are the highest and lowest total debt figures on record for ResMed?

Across the 17 fiscal years on record (2010–2026), the highest was $1.58B in fiscal 2023 and the lowest $100.16M in fiscal 2011.

How does ResMed's debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2026.

How is ResMed's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/RMD/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.